{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:14:50Z","timestamp":1768014890775,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.brainres.2017.01.032","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:30:33Z","timestamp":1486081833000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Effect of MPTP on mRNA expression of PGC-1\u03b1 in mouse brain"],"prefix":"10.1016","volume":"1660","author":[{"given":"Rita","family":"Torok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andras","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelin","family":"Sumegi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denes","family":"Zadori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor","family":"Veres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mate Fort","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laszlo","family":"Vecsei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Klivenyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2017.01.032_b0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2016.11.001","article-title":"ALS-causing mutations differentially affect PGC-1alpha expression and function in the brain vs. peripheral tissues","volume":"97","author":"Bayer","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2017.01.032_b0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(98)00539-4","article-title":"Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain","volume":"251","author":"Binienda","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2017.01.032_b0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2017.01.032_b0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2002.00990.x","article-title":"Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease","volume":"82","author":"Breidert","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2017.01.032_b0025","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease","volume":"95","author":"Brouillet","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2017.01.032_b0030","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1074\/jbc.M111.320200","article-title":"NT-PGC-1alpha protein is sufficient to link beta3-adrenergic receptor activation to transcriptional and physiological components of adaptive thermogenesis","volume":"287","author":"Chang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2017.01.032_b0035","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbrc.2013.05.041","article-title":"A novel PGC-1alpha isoform in brain localizes to mitochondria and associates with PINK1 and VDAC","volume":"435","author":"Choi","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2017.01.032_b0040","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/hmg\/ddr618","article-title":"Sustained expression of PGC-1alpha in the rat nigrostriatal system selectively impairs dopaminergic function","volume":"21","author":"Ciron","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2017.01.032_b0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40478-015-0200-8","article-title":"PGC-1alpha activity in nigral dopamine neurons determines vulnerability to alpha-synuclein","volume":"3","author":"Ciron","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.brainres.2017.01.032_b0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2350-12-69","article-title":"Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease","volume":"12","author":"Clark","year":"2011","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.brainres.2017.01.032_b0055","doi-asserted-by":"crossref","first-page":"e48925","DOI":"10.1371\/journal.pone.0048925","article-title":"Pgc-1alpha overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf","volume":"7","author":"Clark","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brainres.2017.01.032_b0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2017.01.032_b0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2010.02.034","article-title":"Reduced expression of peroxisome-proliferator activated receptor gamma coactivator-1alpha enhances alpha-synuclein oligomerization and down regulates AKT\/GSK3beta signaling pathway in human neuronal cells that inducibly express alpha-synuclein","volume":"473","author":"Ebrahim","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2017.01.032_b0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.24294","article-title":"Mutual exacerbation of peroxisome proliferator-activated receptor gamma coactivator 1alpha deregulation and alpha-synuclein oligomerization","volume":"77","author":"Eschbach","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2017.01.032_b0075","first-page":"600","article-title":"Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations","volume":"60","author":"Forno","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.brainres.2017.01.032_b0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"Suppl 3","key":"10.1016\/j.brainres.2017.01.032_b0085","first-page":"iii29","article-title":"Neurotoxicology: what the neurologist needs to know","volume":"75","author":"Harris","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2017.01.032_b0090","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.STR.0000063404.27912.5B","article-title":"Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats","volume":"34","author":"Horiguchi","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2017.01.032_b0095","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2017.01.032_b0100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/ane.12563","article-title":"The genetic background of Parkinson's disease: current progress and future prospects","volume":"134","author":"Kalinderi","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.brainres.2017.01.032_b0105","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1043-2760(01)00457-X","article-title":"PGC-1, a versatile coactivator","volume":"12","author":"Knutti","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2017.01.032_b0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pbb.2004.03.006","article-title":"Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease","volume":"78","author":"Kurosaki","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2017.01.032_b0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.brainres.2017.01.032_b0120","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00125-015-3671-z","article-title":"The hitchhiker's guide to PGC-1alpha isoform structure and biological functions","volume":"58","author":"Martinez-Redondo","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.brainres.2017.01.032_b0125","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00018-011-0850-z","article-title":"Transgenic expression and activation of PGC-1alpha protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease","volume":"69","author":"Mudo","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.brainres.2017.01.032_b0130","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.25984","article-title":"Cerebellar abnormalities in Huntington's disease: a role in motor and psychiatric impairment?","volume":"29","author":"Rees","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2017.01.032_b0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004647-199703000-00002","article-title":"Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation: \u201cchemical preconditioning\u201d","volume":"17","author":"Riepe","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2017.01.032_b0140","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2012.10.050","article-title":"A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy","volume":"151","author":"Ruas","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2017.01.032_b0145","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/hmg\/dds177","article-title":"A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset","volume":"21","author":"Soyal","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2017.01.032_b0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2017.01.032_b0155","doi-asserted-by":"crossref","first-page":"e0134087","DOI":"10.1371\/journal.pone.0134087","article-title":"PGC-1alpha promoter methylation in Parkinson's disease","volume":"10","author":"Su","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brainres.2017.01.032_b0160","doi-asserted-by":"crossref","first-page":"582809","DOI":"10.1155\/2013\/582809","article-title":"Neuroprotective properties of a novel non-thiazoledinedione partial PPAR- gamma agonist against MPTP","volume":"2013","author":"Swanson","year":"2013","journal-title":"PPAR Res."},{"key":"10.1016\/j.brainres.2017.01.032_b0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-3940(93)90105-T","article-title":"MPTP neurotoxicity to cerebellar Purkinje cells in mice","volume":"150","author":"Takada","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2017.01.032_b0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.24565","article-title":"Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions","volume":"79","author":"Tan","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2017.01.032_b0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/01.CIR.100.5.559","article-title":"Ischemic preconditioning in humans: models, mediators, and clinical relevance","volume":"100","author":"Tomai","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.brainres.2017.01.032_b0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10571-014-0124-z","article-title":"MRNA expression levels of PGC-1alpha in a transgenic and a toxin model of Huntington's disease","volume":"35","author":"Torok","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2017.01.032_b0185","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/00004647-199911000-00007","article-title":"Respiratory chain inhibition induces tolerance to focal cerebral ischemia","volume":"19","author":"Wiegand","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2017.01.032_b0190","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/brain\/aws360","article-title":"The cerebellum in Parkinson's disease","volume":"136","author":"Wu","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2017.01.032_b0195","doi-asserted-by":"crossref","first-page":"32813","DOI":"10.1074\/jbc.M109.037556","article-title":"Alternative mRNA splicing produces a novel biologically active short isoform of PGC-1alpha","volume":"284","author":"Zhang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2017.01.032_b0200","doi-asserted-by":"crossref","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317300458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317300458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T13:59:36Z","timestamp":1655906376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899317300458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":40,"alternative-id":["S0006899317300458"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2017.01.032","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of MPTP on mRNA expression of PGC-1\u03b1 in mouse brain","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2017.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}